1 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Oct 03, 2024
2 Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer! Sep 21, 2024
3 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Aug 15, 2024
4 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Aug 05, 2024
6 J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them Aug 17, 2023
Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
